Alkem Laboratories jumps on incorporating subsidiary in Saudi Arabia
Alkem Laboratories is currently trading at Rs. 5394.00, up by 92.00 points or 1.74% from its previous closing of Rs. 5302.00 on the BSE.
The scrip opened at Rs. 5320.85 and has touched a high and low of Rs. 5474.30 and Rs. 5320.00 respectively. So far 4219 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 5933.00 on 13-Jan-2026 and a 52 week low of Rs. 4879.85 on 22-Oct-2026.
Last one week high and low of the scrip stood at Rs. 5,474.30 and Rs. 5,111.00 respectively. The current market cap of the company is Rs. 64,493.36 `crore.
The promoters holding in the company stood at 49.70%, while Institutions and Non-Institutions held 33.14% and 17.15% respectively.
Alkem Laboratories has incorporated subsidiary in the form of Joint Venture (JV) in the name of ‘Alkem Pharma Company’, Limited Liability Company in the Kingdom of Saudi Arabia on November 8, 2026.
The Subsidiary has been incorporated for manufacture, import, marketing and distribution of pharmaceutical and/or nutraceutical products within the Kingdom of Saudi Arabia. The investment in the Subsidiary is a strategic investment undertaken by the company with the objective of expanding the company’s business and market reach to the Kingdom of Saudi Arabia.
